Sign In
Buy OBSV
$0.102
+0 (+0%)
At Close: Jun 21, 2023
New Forecasts: Here's What Analysts Think The Future Holds For ObsEva SA (NASDAQ:OBSV)
11:55am, Monday, 11'th May 2020
ObsEva SA (NASDAQ:OBSV) shareholders will have a reason to smile today, with the analysts making substantial upgrades...
ObsEva Annual General Meeting 2020
08:30pm, Friday, 08'th May 2020
Geneva, Switzerland and Boston, MA – May 8, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and.
Here's What Analysts Are Forecasting For ObsEva SA (NASDAQ:OBSV) After Its First-Quarter Results
11:58am, Friday, 08'th May 2020
Shareholders will be ecstatic, with their stake up 30% over the past week following ObsEva SA's (NASDAQ:OBSV) latest...
These 3 Biotech Stocks Have Massive Upside Potential, Says Wedbush
01:30pm, Thursday, 07'th May 2020
Take your eye off the ball, and you might have just missed a home run. Veteran players of the stock picking game know that biotechs are capable of delivering a win at what feels like the drop of a hat
ObsEva Announces First Quarter 2020 Financial Results and Business Update
08:34am, Tuesday, 05'th May 2020
No impact from COVID-19 expected on timing of PRIMROSE 1 and 2 and PROLONG trial readouts, enrollment of new patients in EDELWEISS 2 and 3 on temporary holdLinzagolix Phase.
Analysts Offer Insights on Healthcare Companies: ObsEva SA (OBSV) and Homology Medicines (FIXX)
11:14am, Monday, 27'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA (OBSV) and Homology Medicines (FIXX) with bullish
Analysts Offer Insights on Healthcare Companies: ObsEva SA (NASDAQ: OBSV) and Homology Medicines (NASDAQ: FIXX)
11:13am, Monday, 27'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ObsEva SA
Goldman Sachs Group Inc. Sells 48,929 Shares of Obseva SA (NASDAQ:OBSV)
08:18am, Sunday, 26'th Apr 2020
Goldman Sachs Group Inc. reduced its position in Obseva SA (NASDAQ:OBSV) by 50.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm o
How ObsEva (OBSV) Stock Stands Out in a Strong Industry
12:45pm, Thursday, 23'rd Apr 2020
ObsEva (OBSV) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
How ObsEva (OBSV) Stock Stands Out in a Strong Industry
12:45pm, Thursday, 23'rd Apr 2020
ObsEva (OBSV) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt
11:53am, Thursday, 23'rd Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks htitting 52-week highs April 22.) * Dr.Reddy's Laboratories Ltd (NYSE: RDY) * Johns
ObsEva up 10% after hours on long-term linzagolix data
08:57pm, Wednesday, 22'nd Apr 2020
ObsEva SA (NASDAQ:OBSV) perks up 4% after hours on the heels of its announcement of the online publication of two abstracts detailing 52-week data on linzagolix in women endometriosis-related pain.
ObsEva Announces Publication of Abstracts from Phase 2b EDELWEISS Trial of Linzagolix in Endometriosis
08:30pm, Wednesday, 22'nd Apr 2020
ObsEva SA (OBSV) (SIX:OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today reported that there will be an online publicatio
Imagine Owning ObsEva (NASDAQ:OBSV) And Trying To Stomach The 85% Share Price Drop
01:02pm, Tuesday, 21'st Apr 2020
Even the best investor on earth makes unsuccessful investments. But it should be a priority to avoid stomach churning...
Cubist Systematic Strategies LLC Grows Stock Holdings in Obseva SA (NASDAQ:OBSV)
09:20am, Tuesday, 21'st Apr 2020
Cubist Systematic Strategies LLC raised its position in shares of Obseva SA (NASDAQ:OBSV) by 531.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Co
